Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control

High percentage of diabetic people are diagnosed as type 2 who require daily dosing of an antidiabetic drug such as Linagliptin (Lina) to manage their blood glucose levels. This study aimed to develop injectable Lina-loaded biodegradable poly (lactic-co-glycolic acid) (PLGA) in-situ implants (ISIs)...

全面介紹

Saved in:
書目詳細資料
Main Authors: Eman Gomaa (Author), Noura G. Eissa (Author), Tarek M. Ibrahim (Author), Hany M. El-Bassossy (Author), Hanan M. El-Nahas (Author), Margrit M. Ayoub (Author)
格式: 圖書
出版: Elsevier, 2023-04-01T00:00:00Z.
主題:
在線閱讀:Connect to this object online.
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

因特網

Connect to this object online.

3rd Floor Main Library

持有資料詳情 3rd Floor Main Library
索引號: A1234.567
復印件 1 可用